endometrial hyperplasia

Endometrial stripe thickness: a preoperative marker to identify patients with endometrial intraepithelial neoplasia who may benefit from sentinel lymph node mapping and biopsy
Devon Abt, Annliz Macharia, Michele R Hacker, Rasha Baig, Katharine McKinley Esselen, Jennifer Ducie

International Journal of Gynecologic Cancer Sep 2022, 32 (9) 1091-1097; DOI: 10.1136/ijgc-2022-003521
Knowing when to hold and when to fold: sentinel lymph node biopsy in endometrial intraepithelial neoplasia
Anousheh Shafa, Andrea Mariani, Gretchen Glaser

International Journal of Gynecologic Cancer Sep 2022, 32 (9) 1098-1099; DOI: 10.1136/ijgc-2022-003869
Incidence of endometrial carcinoma in patients with endometrial intraepithelial neoplasia versus atypical endometrial polyp
Aviad Cohen, Yossi Tsur, Einat Tako, Ishai Levin, Yaron Gil, Nadav Michaan, Dan Grisaru, Ido Laskov

International Journal of Gynecologic Cancer Jan 2023, 33 (1) 35-41; DOI: 10.1136/ijgc-2022-003991
Multiple attempts at fertility preservation in atypical endometrial hyperplasia and early endometrial cancer
Maria Cecilia Darin, Julian Di Guilmi, Maria Toscano, Florencia Bambaci, Jennifer Chae-Kim

International Journal of Gynecologic Cancer Oct 2022, 32 (10) 1332-1335; DOI: 10.1136/ijgc-2021-003216
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia
Junyu Chen, Dongyan Cao, Jiaxin Yang, Mei Yu, Huimei Zhou, Ninghai Cheng, Jinhui Wang, Ying Zhang, Peng Peng, Keng Shen

International Journal of Gynecologic Cancer Dec 2022, 32 (12) 1561-1567; DOI: 10.1136/ijgc-2022-003882
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review
Natalie Lim, Martha Hickey, Graeme P Young, Finlay A Macrae, Christabel Kelly

International Journal of Gynecologic Cancer May 2022, 32 (5) 646-655; DOI: 10.1136/ijgc-2021-003132
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis
Jennifer Chae-Kim, Gunjal Garg, Larisa Gavrilova-Jordan, Lindsay E Blake, Tongil "TI" Kim, Qiang Wu, Clifford C Hayslip

International Journal of Gynecologic Cancer Dec 2021, 31 (12) 1499-1505; DOI: 10.1136/ijgc-2021-002699
Improving response to progestin treatment of low-grade endometrial cancer
Eva Baxter, Donal J Brennan, Jessica N McAlpine, Jennifer J Mueller, Frédéric Amant, Mignon D J M van Gent, David G Huntsman, Robert L Coleman, Shannon N Westin, Melinda S Yates, Camilla Krakstad, Michael A Quinn, Monika Janda, Andreas Obermair

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1811-1823; DOI: 10.1136/ijgc-2020-001309
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer
Yijiao He, Yiqin Wang, Rong Zhou, Jianliu Wang

International Journal of Gynecologic Cancer Dec 2020, 30 (12) 1902-1907; DOI: 10.1136/ijgc-2020-001570
Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia
Koji Matsuo, Rachel S Mandelbaum, Marcia Ciccone, Mahdi Khoshchehreh, Heena Purswani, Elise B Morocco, Shinya Matsuzaki, Christina E Dancz, Begum Ozel, Richard J Paulson, Lynda Roman

International Journal of Gynecologic Cancer Sep 2020, 30 (9) 1-9; DOI: 10.1136/ijgc-2020-001362

Main menu

endometrial hyperplasia

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

endometrial hyperplasia

Pages